文献速递关节外科

特定现已召回植入物系统行全膝关节翻修术后的结局

Outcomes After Revision Total Knee Arthroplasty From a Specific, Now-Recalled Implant System.
PubMed 文献 · J Arthroplasty · 2023-03-11

单中心分析2010至2020年202例因无菌性指征对该召回型全膝关节置换植入物系统行翻修术的病例。2年和5年无全因再翻修生存率在聚乙烯衬垫更换组为89%和76%,组件翻修组为92%和84%(P=0.5)。男性再翻修风险升高(HR=2.3,P=0.04)。

要点

  • 聚乙烯衬垫更换组与组件翻修组2年及5年无全因再翻修生存率无显著差异(P=0.5)。
  • 同制造商组件翻修组与不同制造商组件翻修组2年及5年生存率无显著差异(P=0.2)。
  • 男性再翻修风险升高(HR=2.3,P=0.04)。

核心结论

  • 在该组对现已召回植入物系统行无菌性翻修的全膝关节置换术中,使用同制造商组件时无再翻修生存率低于预期,但使用替代植入物系统翻修组件时与当代报告相当。
  • 再翻修全膝关节置换时经常使用锥形套和套筒进行干骺端固定以及高限制性植入物。

研究设计与样本

  • 单中心回顾性分析2010年至2020年202例因无菌性指征对特定现已召回全膝关节置换植入物系统行翻修术的病例。
  • 翻修指征包括无菌性松动(n=120)、不稳定(n=55)和聚合物磨损/骨溶解(n=27)。
  • 145例(72%)行组件翻修,57例(28%)行孤立聚乙烯衬垫更换。
  • 采用Kaplan-Meier法和Cox比例风险分析评估无全因再翻修生存率及再翻修危险因素。
  • 证据等级为IV级。

主要发现

  • 2年和5年无全因再翻修生存率在聚乙烯衬垫更换组为89%和76%,在组件翻修组为92%和84%(P=0.5)。
  • 2年和5年生存率在使用同制造商组件翻修组为89%和80%,在使用不同制造商组件翻修组为95%和86%(P=0.2)。
  • 再翻修(n=30)中经常使用锥形套(37%)、套筒(7%)、铰链/股骨远端置换植入物(13%)。
  • 男性再翻修风险升高(风险比=2.3,P=0.04)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A specific total knee arthroplasty (TKA) implant system was recently recalled for high incidence of early polymeric wear and osteolysis. We analyzed the early outcomes of aseptic revision with these implants. METHODS: We identified 202 aseptic revision TKAs of this implant system performed at a single institution between 2010 and 2020. Revision indications included aseptic loosening (n = 120), instability (n = 55), and polymeric wear/osteolysis (n = 27). Components were revised in 145 cases (72%) and isolated polyethylene insert exchange occurred in 57 cases (28%). Kaplan-Meier and Cox proportional hazards analyses were used to determine survivorship free from all-cause rerevision and rerevision risk factors. RESULTS: At 2 and 5 years, survivorship free from all-cause rerevision was 89 and 76% in the polyethylene exchange cohort versus 92 and 84% in the component revision cohort (P = .5). At 2 and 5 years, survivorship in revision with components from the same manufacturer was 89 and 80% compared to 95 and 86% in revision with components from a different manufacturer (P = .2). Among re-revisions (n = 30), cones (37%), sleeves (7%), hinge/distal femoral replacement implants were frequently used (13%). Men had increased risk for rerevision (hazard ratio = 2.3, P = .04). CONCLUSION: In this series of aseptic revision TKAs performed on a now-recalled implant system, survivorship free from rerevision was lower than expected when components from the same manufacturer were utilized, but comparable to contemporary reports when both the components were revised with an alternative implant system. Metaphyseal fixation with cones and sleeves as well as highly constrained implants was frequently utilized at time of rerevision TKA. LEVEL OF EVIDENCE: Level IV.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Puri S, Chandi S, Chiu YF, et al. Outcomes After Revision Total Knee Arthroplasty From a Specific, Now-Recalled Implant System. J Arthroplasty. 2023. PMID: 36907386. doi:10.1016/j.arth.2023.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。